CSF3 and cervical squamous intraepithelial neoplasia: Pegylated granulocyte-colony-stimulating factor (peg-GCSF) was developed to increase the half-life to 46 to 72 hours by attaching polyethylene glycol to filgrastim so that only 1 administration per cycle is necessary to prevent CIN.